Balance Sheet Components

9 Months Ended

Sep. 30, 2026

Balance Sheet Related Disclosures [Abstract]

4. Balance sheet components

Property and equipment, net

Property and equipment, net, consisted of the following (in thousands):


	September 30,			December 31,
	2026			2025
Laboratory equipment		6,803		$	5,251
Computer equipment		946			798
Furniture and fixtures		670			507
Leasehold improvements		691			396
Office equipment		282			184
Construction in progress		396			370
Property and equipment, gross	$	9,788		$	7,506
Less: accumulated depreciation		(2,484	)		(1,013	)
Property and equipment, net	$	7,304		$	6,493

Depreciation expense was $0.5 million and $1.5 million for the three and nine months ended September 30, 2026, and $0.2 million and $0.4 million for the three and nine months ended September 30, 2025, respectively.

Accrued expenses and other current liabilities

Accrued liabilities consisted of the following (in thousands):


	September 30,		December 31,
	2026		2025
Accrued personnel and related expenses	$	13,938	$	9,128
Accrued clinical trial expenses		6,509		9,154
Accrued manufacturing expenses		1,123		2,355
Other		2,403		3,266
Total accrued expenses and other current liabilities	$	23,973	$	23,903